EP1161431A4 - 6-azaindol-verbindungen als antagonisten des gonadotropin-freisetzungs hormones - Google Patents
6-azaindol-verbindungen als antagonisten des gonadotropin-freisetzungs hormonesInfo
- Publication number
- EP1161431A4 EP1161431A4 EP00917757A EP00917757A EP1161431A4 EP 1161431 A4 EP1161431 A4 EP 1161431A4 EP 00917757 A EP00917757 A EP 00917757A EP 00917757 A EP00917757 A EP 00917757A EP 1161431 A4 EP1161431 A4 EP 1161431A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antagonists
- releasing hormone
- gonadotropin releasing
- azaindole compounds
- azaindole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12362099P | 1999-03-10 | 1999-03-10 | |
US123620P | 1999-03-10 | ||
PCT/US2000/005799 WO2000053602A1 (en) | 1999-03-10 | 2000-03-06 | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1161431A1 EP1161431A1 (de) | 2001-12-12 |
EP1161431A4 true EP1161431A4 (de) | 2002-04-24 |
Family
ID=22409767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00917757A Withdrawn EP1161431A4 (de) | 1999-03-10 | 2000-03-06 | 6-azaindol-verbindungen als antagonisten des gonadotropin-freisetzungs hormones |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1161431A4 (de) |
JP (1) | JP2002539124A (de) |
AU (1) | AU3868500A (de) |
CA (1) | CA2366615A1 (de) |
WO (1) | WO2000053602A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002538208A (ja) * | 1999-03-10 | 2002-11-12 | メルク エンド カムパニー インコーポレーテッド | 性腺刺激ホルモン放出ホルモン拮抗薬としての6−アザインドール化合物 |
GB0022670D0 (en) | 2000-09-15 | 2000-11-01 | Astrazeneca Ab | Molecules |
TWI262920B (en) * | 2000-10-27 | 2006-10-01 | Elbion Ag | New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
SE0100566D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
SE0101692D0 (sv) | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
EP1539743B1 (de) | 2002-08-21 | 2007-05-30 | Astrazeneca AB | Pyrazolderivate als gnrh-inhibitoren |
TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
ES2298545T3 (es) | 2002-08-21 | 2008-05-16 | Astrazeneca Ab | Compuestos de tieno-pirrol como antagonistas de la hormona liberadora de gonadotropina. |
TW200413351A (en) * | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
GB0219472D0 (en) | 2002-08-21 | 2002-10-02 | Astrazeneca Ab | Chemical compounds |
WO2005080402A1 (en) * | 2004-02-20 | 2005-09-01 | Astrazeneca Ab | Thienopyroles as antagonists of gnrh |
DE602005010698D1 (de) | 2004-06-09 | 2008-12-11 | Glaxo Group Ltd | Pyrrolopyridinderivate |
DE102004033902A1 (de) | 2004-07-14 | 2006-02-16 | Zentaris Gmbh | Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's) |
DE602005024274D1 (de) | 2004-07-16 | 2010-12-02 | Sunesis Pharmaceuticals Inc | Als aurora-kinase-inhibitoren nutzbare thienopyrimidine |
AU2006272876A1 (en) | 2005-07-22 | 2007-02-01 | Sunesis Pharmaceuticals, Inc. | Pyrazolo pyrimidines useful as aurora kinase inhibitors |
AR067354A1 (es) | 2007-06-29 | 2009-10-07 | Sunesis Pharmaceuticals Inc | Compuestos utiles como inhibidores de la raf quinasa |
US7968536B2 (en) | 2007-06-29 | 2011-06-28 | Millennium Pharmaceuticals, Inc. | Heterocyclic compounds useful as RAF kinase inhibitors |
EP2095818A1 (de) | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Verwendung von LHRH-Antagonisten in nicht-kastrierenden Dosen |
CN113825543A (zh) | 2019-03-19 | 2021-12-21 | 勃林格殷格翰动物保健美国公司 | 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物 |
PE20231205A1 (es) | 2020-05-29 | 2023-08-17 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos heterociclicos como anthelminticos |
MX2023003995A (es) | 2020-10-05 | 2023-06-12 | Enliven Inc | Compuestos de 5-y 6-azaindol para la inhibicion de tirosina cinasas bcr-abl. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997021707A1 (en) * | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
WO1997021703A1 (en) * | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5756507A (en) * | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2298199A (en) * | 1995-02-21 | 1996-08-28 | Merck Sharp & Dohme | Synthesis of azaindoles |
DE69914563T2 (de) * | 1998-10-30 | 2004-12-16 | Eli Lilly And Co., Indianapolis | Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe |
-
2000
- 2000-03-06 JP JP2000604039A patent/JP2002539124A/ja not_active Withdrawn
- 2000-03-06 CA CA002366615A patent/CA2366615A1/en not_active Abandoned
- 2000-03-06 EP EP00917757A patent/EP1161431A4/de not_active Withdrawn
- 2000-03-06 AU AU38685/00A patent/AU3868500A/en not_active Abandoned
- 2000-03-06 WO PCT/US2000/005799 patent/WO2000053602A1/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997021707A1 (en) * | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
WO1997021703A1 (en) * | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5756507A (en) * | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
Non-Patent Citations (1)
Title |
---|
See also references of WO0053602A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2366615A1 (en) | 2000-09-14 |
AU3868500A (en) | 2000-09-28 |
JP2002539124A (ja) | 2002-11-19 |
EP1161431A1 (de) | 2001-12-12 |
WO2000053602A1 (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1171135A4 (de) | 6-azaindolverbindungen als antagonisten des gonadotropin freisetzendes hormons | |
EP1161431A4 (de) | 6-azaindol-verbindungen als antagonisten des gonadotropin-freisetzungs hormones | |
EP0986385A4 (de) | Antagonisten des gonadorelins | |
EP1067930A4 (de) | Antagonisten des gonadoliberins | |
EP0986557A4 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
AU4834900A (en) | Antagonists of gonadotropin releasing hormone | |
EP1165075A4 (de) | 6-azaindolverbindungen als antagonisten des gonadoliberins | |
EP1011667A4 (de) | Antagonisten des gonadotrophin freisetzungs hormons | |
EP1027046A4 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
EP0901471A4 (de) | Antagonisten des gonadotropin-releasing-hormons | |
EP1049472A4 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
EP0920319A4 (de) | Antagonisten des gonadotropin freisetzenden hormins | |
HK1051142A1 (en) | Formulation of substituted benzimidazoles | |
EP1171126A4 (de) | 6-azaindolverbindungen als antagonisten des gonadotropin freisetzendes hormons | |
EP1165076A4 (de) | 6-azaindolverbindungen als antagonisten des gonadoliberins | |
PL350536A1 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor | |
EP1062215A4 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
AU4742101A (en) | Antagonists of gonadotropin releasing hormone | |
AU4738101A (en) | Antagonists of gonadotropin releasing hormone | |
GB9907082D0 (en) | The preparation of carboxylic acid derivatives | |
GB9809789D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9800451D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9815847D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9815854D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9812217D0 (en) | Antagonists of gonadotropin releasing hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011010 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20011010;LT PAYMENT 20011010;LV PAYMENT 20011010;MK PAYMENT 20011010;RO PAYMENT 20011010;SI PAYMENT 20011010 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020308 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07D 471/04 A, 7C 07D 471/08 B, 7C 07D 401/06 B, 7C 07D 401/12 B, 7A 61K 31/44 B, 7A 61K 31/435 B, 7A 61P 15/00 B |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020701 |